0

Effect of Slow Release Nifedipine Tablets in Patients With Essential Hypertension

Y Imai, K Abe, M Munakata, S Sasaki, N Minami, H Sakuma, J Hashimoto, N Watanabe, M Sakuma, H Sekino

Arzneimittelforschung. 1992 Dec;42(12):1434-8.

PMID: 1288507

Abstract:

The antihypertensive effect of slow release nifedipine (CAS 21829-25-4) tablets (20 mg, Adalat) administered once or twice daily was studied in patients with essential hypertension of WHO stage I or II. Ambulatory blood pressure was monitored by a finger volume oscillometric device every 5 min for 24 h before and during the treatment with nifedipine. Whether administered once or twice daily, nifedipine tablets dit not change the pattern of circadian blood pressure variation; i.e. diurnal rise and nocturnal fall. Twice daily administration induced a significant downward shift in the blood pressure pattern. In other words, further hypotensive effect was observed during the night when the blood pressure was already low. On the other hand, administration once daily in the morning lowered daytime blood pressure without affecting blood pressure during the night. The duration of action of nifedipine tablets administered once daily was 12 h or more. In the acute experiment using 20 mg tablets of nifedipine, plasma concentration of nifedipine was well correlated with the percentage change in mean blood pressure. The minimal effective plasma concentration of nifedipine was estimated to be 13.4 ng/ml. However, in chronic treatment, nifedipine lowered blood pressure at the plasma concentration of 10 ng/ml. The results indicate that nifedipine tablets administered once daily provide an effective antihypertensive regimen for controlling daytime hypertension with minimal antihypertensive effect during the night.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP21829254-A Nifedipine - CAS 21829-25-4 Nifedipine - CAS 21829-25-4 21829-25-4 Price
qrcode